Should you buy, hold or sell Tata Consumer, Titan, Berger Paints, Birlasoft, Godrej Properties shares now?

Top brokerages have shared a number of calls as Dalal Street enters the February 3 session, days after Finance Minister Nirmala Sitharaman unveiled a wholesome Budget 2023. On their radar are stocks such as HDFC, Tata Consumer and Titan. 

Here's the complete list of brokerage views on some of the key stocks in focus today:

Titan shares

CLSA highlighted double-digit revenue growth across segments in Titan's quarterly numbers but also pointed out moderate margins.  Investors will get an even more attractive entry point after a correction, according to the brokerage.  

JPMorgan said Titan's EBITDA was three per cent below its estimate owing to lower-than-expected margins in its jewellery and watch businesses, though the key focus was a positive demand narrative amid high gold prices and a softening urban discretionary sentiment. 

Here's how brokerages rate Titan:

HDFC shares

HSBC maintained a 'buy' rating on HDFC and reduced its target to Rs 2,850 from Rs 2,990. 

Godrej Properties shares

Tata Consumer shares

Morgan Stanley retained an 'overweight' call with a target price of Rs 904. 

Dabur shares

According to CLSA, a rural slowdown is a critical factor for a rerating of Dabur shares, as the company's higher rural salience affects its growth.

Birlasoft shares

Macquarie continued with an 'outperform' rating on Birlasoft with a target price of Rs 500.

Berger Paints shares

Morgan Stanley maintained an 'unverweight' rating on Berger Paints and reduced its target price by Rs 68 to Rs 507, citing changing industry dynamics and margin headwinds. 

The company's quarterly performance fell short of estimates, though its market share gain and focus on an accelerating pace of network expansion are positives, according to the brokerage. 

Aditya Birla Capital shares

According to Morgan Stanley, which has an 'equal-weight' call on Aditya Birla Capital shares with a target price of Rs 163, the company's consolidated net profit before exceptionals came in six per cent above the brokerage's estimates owing to change in its health insurance business. 

AB Capital's life insurance business continues to show strong growth in annual premium equivalent (APE) and value of new business (VNB) margin progression, according to the brokerage.

Apollo Tyres shares

Morgan Stanley maintained an 'overweight' call on Apollo Tyres with a target price of Rs 348. 

Dr Lal Pathlabs shares

Morgan Stanley maintained an 'equal'weight' rating on Dr Lal Pathlabs with a target price of Rs 2,214 — implying upside potential of 9.6 per cent from the diagnostic company stock's closing price on Thursday. 

Crompton Greaves Consumer shares

Tata Chemicals shares

Morgan Stanley kept an 'overweight' call on Tata Chemicals with a target price of Rs 1,278.

Catch LIVE stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.